We are live on ! Find out more
AGN

Allergan Inc
AGN

Delisted

AGN was delisted on the 16th of March, 2015.

Back to rankings

9 hedge funds and large institutions have $12.7M invested in Allergan Inc in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more capital invested

Capital invested by funds: $11.1M → $12.7M (+$1.6M)

13% more funds holding

Funds holding: 8 → 9 (+1)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CA
Callahan Advisors
Texas
+$22.9K
2
EWM
Elmwood Wealth Management
California
+$13.1K
3
ARMC
American Research & Management Company
Massachusetts
+$6K

Top Sellers

Rank Fund Capital Flow
1
MMPW
Mitchell McLeod Pugh & Williams
Alabama
-$15.2K
2
CAM
Cubic Asset Management
Massachusetts
-$1.91K
Name Holding Trade Value Shares
Change 		Change in
Stake
GIM
1
Grassi Investment Management
California
$8.25M – – –
CA
2
Callahan Advisors
Texas
$2.94M +$22.9K +120 +0.8%
MMPW
3
Mitchell McLeod Pugh & Williams
Alabama
$734K -$15.2K -80 -2%
CAM
4
Cubic Asset Management
Massachusetts
$404K -$1.91K -10 -0.5%
SCA
5
STALEY CAPITAL ADVISERS
Pennsylvania
$267K – – –
SIAP
6
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$36K – – –
GAM
7
Gemmer Asset Management
California
$22K – – –
EWM
8
Elmwood Wealth Management
California
$19K +$13.1K +69 +223%
ARMC
9
American Research & Management Company
Massachusetts
$6K +$6K +33 New

AGN Hedge Fund Activity: Q3 2018 in Review

9 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q3 2018, worth a combined $12.7M — up 14% from $11.1M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new AGN positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Callahan Advisors, adding an estimated $22.9K. The largest seller was Mitchell McLeod Pugh & Williams, cutting an estimated $15.2K.

  • 9 institutional investors held Allergan Inc (AGN) as of Q3 2018, up from 8 in Q2 2018.
  • Funds reported $12.7M of Allergan Inc stock for Q3 2018, up 14% quarter-over-quarter.
  • 1 fund opened new Allergan Inc positions in Q3 2018 and 0 closed out, a net change of +1 holder.
  • The largest Allergan Inc buyer in Q3 2018 was Callahan Advisors, an estimated $22.9K added.
  • The largest Allergan Inc seller in Q3 2018 was Mitchell McLeod Pugh & Williams, an estimated $15.2K sold.

Based on aggregated 13F filings for Q3 2018.